共 20 条
[2]
Lorlatinib as a treatment for ALK-positive lung cancer
[J].
FUTURE ONCOLOGY,
2022, 18 (24)
:2745-2766
[5]
Devaraju Ramaraju, 2014, BMJ Case Rep, V2014, pbcr, DOI 10.1136/bcr-2013-202776
[7]
Huang Y, 2016, Zhonghua Bing Li Xue Za Zhi, V45, P612, DOI 10.3760/cma.j.issn.0529-5807.2016.09.005
[9]
Jiang L, 2014, INT J CLIN EXP PATHO, V7, P6792